The distinguishing cellular features of pulmonary artery smooth muscle cells from chronic thromboembolic pulmonary hypertension patients

Exp Lung Res. 2013 Oct;39(8):349-58. doi: 10.3109/01902148.2013.822947.

Abstract

In chronic thromboembolic pulmonary hypertension (CTEPH), central thrombi are the most likely disease initiators, and progressive pulmonary vascular remodeling, which is characterized by marked proliferation of pulmonary artery smooth muscle cells (PASMCs), may also contribute to the long-term progression of CTEPH. This study was designed to investigate the cellular characteristics of PASMCs isolated from the organized thrombotic tissues of CTEPH. In the present study, analysis of PASMCs isolated from five CTEPH patients and three control subjects showed that cells from CTEPH patients had certain characteristics that distinguished them from control cells, including inferior or no cell-cell contact inhibition growth, increased sensitivity to hypoxia-induced proliferation, resistance to serum starvation-induced apoptosis, and mitochondrial metabolism disorder. These differences in the PASMCs in endarterectomized tissue of CTEPH patients may prove useful in understanding the pathobiology of CTEPH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Apoptosis
  • Case-Control Studies
  • Cell Hypoxia
  • Cell Proliferation
  • Chronic Disease
  • Contact Inhibition
  • Disease Progression
  • Endarterectomy
  • Female
  • Humans
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / pathology*
  • Hypertension, Pulmonary / surgery
  • Male
  • Middle Aged
  • Mitochondria / metabolism
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology*
  • Pulmonary Artery / metabolism
  • Pulmonary Artery / pathology*
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / pathology*
  • Pulmonary Embolism / surgery